EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Microphysiological Systems for Cancer Immunotherapy Research and Development

Yansong Peng, Esak Lee iD

Advanced Biology · 2024

DOI: 10.1002/adbi.202300077 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Biology, 2024. Verfasst von Yansong Peng und 1 weiteren Autor:innen. Beteiligte Einrichtung: Nancy E. and Peter C. Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY, 14853, USA. Hauptthemen laut MEDLINE: Immunotherapy, Microphysiological Systems, Neoplasms. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer immunotherapy focuses on the use of patients’ adaptive immune systems to combat cancer. In the past decade, FDA has approved many immunotherapy products for cancer patients who suffer from primary tumors, tumor relapse, and metastases. However, these immunotherapies still show resistance in many patients and often lead to inconsistent responses in patients due to variations in tumor genetic mutations and tumor immune microenvironment. Microfluidics‐based organ‐on‐a‐chip technologies or microphysiological systems have opened new ways that can provide relatively fast screening for personalized immunotherapy and help researchers and clinicians understand tumor‐immune interactions in a patient‐specific manner. They also have the potential to overcome the limitations of traditional drug screening and testing, given the models provide a more realistic 3D microenvironment with better controllability, reproducibility, and physiological relevance. This review focuses on the cutting‐edge microphysiological organ‐on‐a‐chip devices developed in recent years for studying cancer immunity and testing cancer immunotherapeutic agents, as well as some of the largest challenges of translating this technology to clinical applications in immunotherapy and personalized medicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyMicrophysiological SystemsNeoplasmsAnimalsHumansPrecision MedicineTumor Microenvironment

Stichwörter der Autor:innen

engineered T cell therapyimmune checkpoint blockadeimmunotherapymicrophysiological systemtumor immune microenvironment

Autor:innen und Institutionen

  • Nancy E. and Peter C. Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY, 14853, USA.

ORCID-Profile: Esak Lee

Förderung

  • NHLBI NIH HHS
  • NIH HHS
  • NCI NIH HHS
  • NIAID NIH HHS
  • International Foundation for Ethical Research
  • National Institutes of Health

Zitieren

APA

Peng, Y., & Lee, E. (2024). Microphysiological Systems for Cancer Immunotherapy Research and Development. Advanced Biology. https://doi.org/10.1002/adbi.202300077

Vancouver

Peng Y, Lee E. Microphysiological Systems for Cancer Immunotherapy Research and Development. Advanced Biology. 2024. doi:10.1002/adbi.202300077

BibTeX
@article{Peng2024,
  author = {Peng, Yansong and Lee, Esak},
  title = {Microphysiological Systems for Cancer Immunotherapy Research and Development},
  journal = {Advanced Biology},
  year = {2024},
  doi = {10.1002/adbi.202300077}
}
Kostenlos starten →